Evidence map›Paper›PMID 35053230›Full record

ReviewBiomolecules2022

Nrf2-Related Therapeutic Effects of Curcumin in Different Disorders.

Soudeh Ghafouri-Fard, Hamed Shoorei, Zahra Bahroudi, Bashdar Mahmud Hussen, Seyedeh Fahimeh Talebi, Mohammad Taheri, Seyed Abdulmajid Ayatollahi

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Curcumin's Protective Effects Against HMolecules (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Plants (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Review
  8. Curcumin Between Pleiotropic Potential and Translational Constraints.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Molecular mechanisms of ferroptosis in cardiovascular disease.Molecular and cellular biochemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Soudeh Ghafouri-FardDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 16666-63111, Iran.ORCID 0000-0002-0223-499X
Hamed ShooreiDepartment of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand 9717853577, Iran.ORCID 0000-0002-7762-5362
Zahra BahroudiDepartment of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166-15731, Iran.
Bashdar Mahmud HussenDepartment of Pharmacognosy, College of Pharmacy, Hawler Medical University, Erbil 44001, Kurdistan Region, Iraq.ORCID 0000-0003-1060-6527
Seyedeh Fahimeh TalebiDepartment of Pharmacology, College of Pharmacy, Birjand University of Medical Sciences, Birjand 9717853577, Iran.
Mohammad TaheriInstitute of Human Genetics, Jena University Hospital, 07743 Jena, Germany.
Seyed Abdulmajid AyatollahiPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 16666-63111, Iran.
Birjand University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRHawler Medical University · IQJena University Hospital · DETabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin is a natural polyphenol with antioxidant, antibacterial, anti-cancer, and anti-inflammation effects. This substance has been shown to affect the activity of Nrf2 signaling, a pathway that is activated in response to stress and decreases levels of reactive oxygen species and electrophilic substances. Nrf2-related effects of curcumin have been investigated in different contexts, including gastrointestinal disorders, ischemia-reperfusion injury, diabetes mellitus, nervous system diseases, renal diseases, pulmonary diseases, cardiovascular diseases as well as cancers. In the current review, we discuss the Nrf2-mediated therapeutic effects of curcumin in these conditions. The data reviewed in the current manuscript indicates curcumin as a potential activator of Nrf2 and a therapeutic substance for the protection of cells in several pathological conditions.

Indexed as

AnimalsAntioxidantsCurcuminHumansNF-E2-Related Factor 2Reactive Oxygen SpeciesSignal TransductionAntioxidantsCurcuminNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciescancercurcumindisordersNrf2

Identifiers

PMID35053230
PMCPMC8773597
OpenAlexW4206226997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.